Henry Schein, Inc. (HSIC) EPS CAGR:1.72%(TTM)
EPS CAGR uses precomputed diluted earnings history where available.
Over longer horizons, Henry Schein, Inc.'s EPS CAGR averages -7.60% over 3 years and -0.74% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. EPS (Earnings Per Share) CAGR measures how Henry Schein, Inc.'s earnings per share have grown. This is a key metric for valuation and reflects profitability on a per-share basis.
HSIC EPS CAGR Chart
Henry Schein, Inc. (HSIC)
HSIC Quarterly EPS Growth (YoY)
EPS growth vs the same quarter one year earlier, last 20 quarters.
HSIC EPS CAGR History
| Year | Start EPS | End EPS | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $3.07 | $3.29 | +$0.22 | +7.17% | +7.17% |
| 2024 | $3.18 | $3.07 | $-0.11 | -3.46% | -3.46% |
| 2023 | $3.95 | $3.18 | $-0.77 | -19.49% | -19.49% |
| 2022 | $4.51 | $3.95 | $-0.56 | -12.42% | -12.42% |
| 2021 | $2.82 | $4.51 | +$1.69 | +59.93% | +59.93% |
| 2020 | $3.44 | $2.82 | $-0.62 | -18.02% | -18.02% |
| 2019 | $3.51 | $3.44 | $-0.07 | -1.99% | -1.99% |
| 2018 | $2.59 | $3.51 | +$0.92 | +35.52% | +35.52% |
| 2017 | $3.16 | $2.59 | $-0.57 | -18.04% | -18.04% |
| 2016 | $2.89 | $3.16 | +$0.27 | +9.34% | +9.34% |
| 2015 | $2.77 | $2.89 | +$0.12 | +4.33% | +4.33% |
| 2014 | $2.58 | $2.77 | +$0.19 | +7.36% | +7.36% |
| 2013 | $2.22 | $2.58 | +$0.36 | +16.22% | +16.22% |
| 2012 | $2.04 | $2.22 | +$0.18 | +8.82% | +8.82% |
| 2011 | $1.81 | $2.04 | +$0.23 | +12.71% | +12.71% |
| 2010 | $1.74 | $1.81 | +$0.07 | +4.02% | +4.02% |
| 2009 | $1.39 | $1.74 | +$0.35 | +25.18% | +25.18% |
| 2008 | $1.33 | $1.39 | +$0.06 | +4.51% | +4.51% |
| 2007 | $1.04 | $1.33 | +$0.29 | +27.88% | +27.88% |
| 2006 | $0.87 | $1.04 | +$0.17 | +19.54% | +19.54% |
| 2005 | $0.74 | $0.87 | +$0.13 | +17.57% | +17.57% |
| 2004 | $0.79 | $0.74 | $-0.05 | -6.33% | -6.33% |
| 2003 | $0.67 | $0.79 | +$0.12 | +17.91% | +17.91% |
| 2002 | $0.26 | $0.67 | +$0.41 | +157.69% | +157.69% |
| 2001 | $0.17 | $0.26 | +$0.09 | +52.94% | +52.94% |
| 2000 | $0.04 | $0.17 | +$0.13 | +323.94% | +323.94% |
| 1999 | $0.01 | $0.04 | +$0.03 | +208.46% | +208.46% |
| 1998 | $-0.00 | $0.01 | +$0.01 | N/A | N/A |
| 1997 | $0.02 | $-0.00 | $-0.02 | -105.19% | N/A |
Quarterly EPS: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $0.93 | +8.1% | +4.5% |
| Q4 2025 | $0.86 | +2.4% | +14.7% |
| Q3 2025 | $0.84 | +18.3% | +6.3% |
| Q2 2025 | $0.71 | -20.2% | -12.3% |
| Q1 2025 | $0.89 | +18.7% | +23.6% |
| Q4 2024 | $0.75 | -5.1% | +435.7% |
| Q3 2024 | $0.79 | -2.5% | -24.8% |
| Q2 2024 | $0.81 | +12.5% | -24.3% |
| Q1 2024 | $0.72 | +414.3% | -21.7% |
| Q4 2023 | $0.14 | -86.7% | -60.0% |
| Q3 2023 | $1.05 | -1.9% | -5.4% |
| Q2 2023 | $1.07 | +16.3% | -7.8% |
| Q1 2023 | $0.92 | +162.9% | -30.3% |
| Q4 2022 | $0.35 | -68.5% | -67.0% |
| Q3 2022 | $1.11 | -4.3% | +0.0% |
| Q2 2022 | $1.16 | -12.1% | +4.5% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Andrea Albertini